{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:52:17Z","timestamp":1790801537597,"version":"4.1.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,10]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Eczematous eruption is an increasingly recognized form of drug-related eruption, typically reported in association with interleukin 17 (IL-17)A inhibitors. However, severe paradoxical eczematous eruption due to IL-17A inhibitors has been rarely reported. Herein, we reported a case of a man with severe psoriasis with erythematous scaly plaques on the scalp, trunk, and arms and legs after the administration of secukinumab was initiated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We reported a case of a 20-year-old man with severe psoriasis with erythematous scaly plaques on the scalp, trunk, and arms and legs after the administration of secukinumab was initiated. A skin biopsy was performed. It revealed spongiotic dermatitis consistent with eczematous reaction. Direct and indirect immunofluorescence assays were negative.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>He was diagnosed with eczematous eruption.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>Discontinuation of secukinumab and administration of cyclosporine and prednisone were considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Significant improvement was observed, with no adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our case shows that eczematous eruption can paradoxically occur in patients on IL-17A inhibitors and this report is expected to increase awareness of the rising number of cutaneous eruptions related to biological agents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000032844","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:00:43Z","timestamp":1676044843000},"page":"e32844","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Treatment of paradoxical eczematous eruption in psoriasis treated with secukinumab: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Yu","family":"Xiao","sequence":"first","affiliation":[{"name":"The Central Hospital of Xiaogan, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Peng","sequence":"additional","affiliation":[{"name":"The Central Hospital of Xiaogan, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Li","sequence":"additional","affiliation":[{"name":"The Central Hospital of Xiaogan, Jinzhou Medical University, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Mao","sequence":"additional","affiliation":[{"name":"The Central Hospital of Xiaogan, Jinzhou Medical University, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muping","family":"Fang","sequence":"additional","affiliation":[{"name":"The Central Hospital of Xiaogan, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhong","family":"Hu","sequence":"additional","affiliation":[{"name":"The Central Hospital of Xiaogan, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Hubei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1506-2573","authenticated-orcid":false,"given":"Wenzheng","family":"Ye","sequence":"additional","affiliation":[{"name":"The Central Hospital of Xiaogan, Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis.","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet (London, England)"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review.","volume":"34","author":"Al-Janabi","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/ijd.14695","article-title":"IL-17 and its role in inflammatory, autoimmune, and oncological skin diseases: state of art.","volume":"59","author":"Bernardini","year":"2020","journal-title":"Int J Dermatol"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/14712598.2020.1727439","article-title":"Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.","volume":"20","author":"Caldarola","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000513467","article-title":"Atopic dermatitis as a paradoxical effect of secukinumab for the treatment of psoriasis.","volume":"13","author":"Mendes Roncada","year":"2021","journal-title":"Case Rep Dermatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jamadermatol.2019.1268","article-title":"Morphologic switch from psoriasiform to eczematous dermatitis after Anti-IL-17 therapy: a case series.","volume":"155","author":"Lai","year":"2019","journal-title":"JAMA Dermatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s40257-021-00586-8","article-title":"Eczematous drug eruptions.","volume":"22","author":"Blum","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jdcr.2021.03.006","article-title":"Eczematous reactions to psoriasis biologics treated with dupilumab: a case series.","volume":"11","author":"Koschitzky","year":"2021","journal-title":"JAAD Case Rep"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/jdv.14888","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II.","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ced.15052","article-title":"Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?","volume":"47","author":"Megna","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/cup.13055","article-title":"TNFalpha and IL-17A are differentially expressed in psoriasis-like versus eczema-like drug reactions to TNFalpha antagonists.","volume":"45","author":"Deubelbeiss","year":"2018","journal-title":"J Cutan Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T03:00:44Z","timestamp":1746327644000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000032844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000032844","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,10]]}}}